Vontobel Holding
GRCL

Vontobel Holding’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Vontobel Holding’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$139K – 1240
2021
Q3 		$139K Hold
10,000
– – ﹤0.01% 1069
2021
Q2 		$130K Buy
+10,000
New +$134K ﹤0.01% 1061

Other funds holding GRCL

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vontobel Holding's GRCL Position: Q4 2021 in Review

Vontobel Holding sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q4 2021, closing a stake of 10,000 shares — an estimated $139K sold.

Vontobel Holding first reported a position in GRCL in Q2 2021 and held it in 2 quarters. The position peaked at $139K in Q3 2021. 35 funds tracked by Wall St. Rank hold GRCL as of Q4 2021.

  • Vontobel Holding reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Vontobel Holding sold 10,000 Gracell Biotechnologies Inc. American Depositary Shares shares in Q4 2021, an estimated $139K.
  • Vontobel Holding first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q2 2021 and held it in 2 quarters.
  • Vontobel Holding's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $139K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q4 2021.

Based on Vontobel Holding's 13F filing for Q4 2021, filed 10 Feb 2022.